Flavonoids, dairy foods, and cardiovascular and metabolic health: A review of emerging biologic pathways

Circulation Research

Volumn 122, Issue 2, 2018, Pages 369-384

  Mozaffarian, Dariush ^a   Wu, Jason H Y ^b  

^a TUFTS UNIVERSITY   (United States)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Cardiovascular disease; Cheese; Diabetes mellitus; Flavonoids; Milk; Review; Yogurt

Indexed keywords

CALCIUM; FARNOQUINONE; FLAVONOID; MILK FAT; NITRIC OXIDE SYNTHASE; PHYTOMENADIONE; PROBIOTIC AGENT; VITAMIN K GROUP;

ANTIINFLAMMATORY ACTIVITY; BIOAVAILABILITY; BLOOD VESSEL FUNCTION; BODY WEIGHT CONTROL; CARDIOVASCULAR DISEASE; CHEESE; CLINICAL EFFECTIVENESS; COLON FLORA; DAIRY PRODUCT; DIET SUPPLEMENTATION; DRUG MECHANISM; FAT INTAKE; FERMENTATION; GLUCOSE HOMEOSTASIS; HOMEOSTASIS; HUMAN; INSULIN HOMEOSTASIS; METABOLIC DISORDER; NONHUMAN; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN INTAKE; REVIEW; VASOREGULATION; ANIMAL; CARDIOVASCULAR SYSTEM; DIET THERAPY; DRUG EFFECT; ENERGY METABOLISM; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; DAIRY PRODUCTS; ENERGY METABOLISM; FLAVONOIDS; HUMANS; METABOLIC DISEASES; SIGNAL TRANSDUCTION;

EID: 85044988819     PISSN: 00097330     EISSN: 15244571     Source Type: Journal    
DOI: 10.1161/CIRCRESAHA.117.309008     Document Type: Review

References (252)

1. Mozaffarian D. Dietary and policy priorities for cardiovascular disease, diabetes, and obesity: a comprehensive review. Circulation. 2016;133:187-225. doi: 10.1161/CIRCULATIONAHA.115.018585.
2. Micha R, Peñalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA. 2017;317:912-924. doi: 10.1001/jama.2017.0947.
3. Bloom D, Cafiero E, Jané-Llopis E, Abrahams-Gessel S, Bloom L, Fathima S, Feigl A, Gaziano T, Mowafi M, Pandya A, Prettner K, Rosenberg L, Seligman B, Stein A, Weinstein C. The Global Economic Burden of Noncommunicable Diseases. Geneva, Switzerland: World Economic Forum; 2011.
4. Cassidy A, O'Reilly ÉJ, Kay C, Sampson L, Franz M, Forman JP, Curhan G, Rimm EB. Habitual intake of flavonoid subclasses and incident hypertension in adults. Am J Clin Nutr. 2011;93:338-347. doi: 10.3945/ajcn.110.006783.
5. Ding M, Pan A, Manson JE, Willett WC, Malik V, Rosner B, Giovannucci E, Hu FB, Sun Q. Consumption of soy foods and isoflavones and risk of type 2 diabetes: a pooled analysis of three US cohorts. Eur J Clin Nutr. 2016;70:1381-1387. doi: 10.1038/ejcn.2016.117.
6. Gu L, Kelm MA, Hammerstone JF, Beecher G, Holden J, Haytowitz D, Gebhardt S, Prior RL. Concentrations of proanthocyanidins in common foods and estimations of normal consumption. J Nutr. 2004;134:613-617.
7. Bondonno CP, Croft KD, Ward N, Considine MJ, Hodgson JM. Dietary flavonoids and nitrate: effects on nitric oxide and vascular function. Nutr Rev. 2015;73:216-235. doi: 10.1093/nutrit/nuu014.
8. Cassidy A, Minihane AM. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. Am J Clin Nutr. 2017;105:10-22. doi: 10.3945/ajcn.116.136051.
9. Goya L, Martín MÁ, Sarriá B, Ramos S, Mateos R, Bravo L. Effect of cocoa and its flavonoids on biomarkers of inflammation: studies of cell culture, animals and humans. Nutrients. 2016;8:212. doi: 10.3390/nu8040212.
10. Legeay S, Rodier M, Fillon L, Faure S, Clere N. Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome. Nutrients. 2015;7:5443-5468. doi: 10.3390/nu7075230.
11. Mangels DR, Mohler ER III. Catechins as potential mediators of cardiovascular health. Arterioscler Thromb Vasc Biol. 2017;37:757-763. doi: 10.1161/ATVBAHA.117.309048.
12. Ramdath DD, Padhi EM, Sarfaraz S, Renwick S, Duncan AM. Beyond the cholesterol-lowering effect of soy protein: a review of the effects of dietary soy and its constituents on risk factors for cardiovascular disease. Nutrients. 2017;9:E324. doi: 10.3390/nu9040324.
13. Talaei M, Pan A. Role of phytoestrogens in prevention and management of type 2 diabetes. World J Diabetes. 2015;6:271-283. doi: 10.4239/wjd. v6.i2.271.
14. Vitale DC, Piazza C, Melilli B, Drago F, Salomone S. Isoflavones: estrogenic activity, biological effect and bioavailability. Eur J Drug Metab Pharmacokinet. 2013;38:15-25. doi: 10.1007/s13318-012-0112-y.
15. Williamson G, Clifford MN. Colonic metabolites of berry polyphenols: the missing link to biological activity? Br J Nutr. 2010;104(suppl 3):S48-S66. doi: 10.1017/S0007114510003946.
16. van Duynhoven J, Vaughan EE, Jacobs DM, Kemperman RA, van Velzen EJ, Gross G, Roger LC, Possemiers S, Smilde AK, Dore J, Westerhuis JA, Van de Wiele T. Metabolic fate of polyphenols in the human superorganism. Proc Nat Acad Sci USA. 2011;108(suppl 1):4531-4538.
17. Czank C, Cassidy A, Zhang Q, Morrison DJ, Preston T, Kroon PA, Botting NP, Kay CD. Human metabolism and elimination of the anthocyanin, cyanidin-3-glucoside: a (13)C-tracer study. Am J Clin Nutr. 2013;97:995-1003. doi: 10.3945/ajcn.112.049247.
18. de Ferrars RM, Czank C, Zhang Q, Botting NP, Kroon PA, Cassidy A, Kay CD. The pharmacokinetics of anthocyanins and their metabolites in humans. Br J Pharmacol. 2014;171:3268-3282. doi: 10.1111/bph.12676.
19. van Duynhoven J, van der Hooft JJ, van Dorsten FA, Peters S, Foltz M, Gomez-Roldan V, Vervoort J, de Vos RC, Jacobs DM. Rapid and sustained systemic circulation of conjugated gut microbial catabolites after singledose black tea extract consumption. J Proteome Res. 2014;13:2668-2678. doi: 10.1021/pr5001253.
20. Amin HP, Czank C, Raheem S, Zhang Q, Botting NP, Cassidy A, Kay CD. Anthocyanins and their physiologically relevant metabolites alter the expression of IL-6 and VCAM-1 in CD40L and oxidized LDL challenged vascular endothelial cells. Mol Nutr Food Res. 2015;59:1095-1106. doi: 10.1002/mnfr.201400803.
21. di Gesso JL, Kerr JS, Zhang Q, Raheem S, Yalamanchili SK, O'Hagan D, Kay CD, O'Connell MA. Flavonoid metabolites reduce tumor necrosis factor-α secretion to a greater extent than their precursor compounds in human THP-1 monocytes. Mol Nutr Food Res. 2015;59:1143-1154. doi: 10.1002/mnfr.201400799.
22. Warner EF, Zhang Q, Raheem KS, O'Hagan D, O'Connell MA, Kay CD. Common phenolic metabolites of flavonoids, but not their unmetabolized precursors, reduce the secretion of vascular cellular adhesion molecules by human endothelial cells. J Nutr. 2016;146:465-473. doi: 10.3945/jn.115.217943.
23. Fernández-Millán E, Ramos S, Alvarez C, Bravo L, Goya L, Martín MÁ. Microbial phenolic metabolites improve glucose-stimulated insulin secretion and protect pancreatic beta cells against tert-butyl hydroperoxide-induced toxicity via ERKs and PKC pathways. Food Chem Toxicol. 2014;66:245-253. doi: 10.1016/j.fct.2014.01.044.
24. Kemperman RA, Gross G, Mondot S, Possemiers S, Marzorati M, de Wiele TV, Dore J, Vaughan EE. Impact of polyphenols from black tea and red wine/grape juice on a gut model microbiome. Food Res Intern. 2013;53:659-669.
25. Ruan JQ, Li S, Li YP, Wu WJ, Lee SM, Yan R. The presystemic interplay between gut microbiota and orally administered calycosin-7-O-β- D-glucoside. Drug Metab Dispos. 2015;43:1601-1611. doi: 10.1124/dmd.115.065094.
26. Anhê FF, Roy D, Pilon G, Dudonné S, Matamoros S, Varin TV, Garofalo C, Moine Q, Desjardins Y, Levy E, Marette A. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut. 2015;64:872-883. doi: 10.1136/gutjnl-2014-307142.
27. Roopchand DE, Carmody RN, Kuhn P, Moskal K, Rojas-Silva P, Turnbaugh PJ, Raskin I. Dietary polyphenols promote growth of the gut bacterium Akkermansia muciniphila and attenuate high-fat diet-induced metabolic syndrome. Diabetes. 2015;64:2847-2858. doi: 10.2337/db14-1916.
28. Collins B, Hoffman J, Martinez K, Grace M, Lila MA, Cockrell C, Nadimpalli A, Chang E, Chuang CC, Zhong W, Mackert J, Shen W, Cooney P, Hopkins R, McIntosh M. A polyphenol-rich fraction obtained from table grapes decreases adiposity, insulin resistance and markers of inflammation and impacts gut microbiota in high-fat-fed mice. J Nutr Biochem. 2016;31:150-165. doi: 10.1016/j.jnutbio.2015.12.021.
29. Everard A, Belzer C, Geurts L, Ouwerkerk JP, Druart C, Bindels LB, Guiot Y, Derrien M, Muccioli GG, Delzenne NM, de Vos WM, Cani PD. Crosstalk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci USA. 2013;110:9066-9071.
30. Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23:107-113. doi: 10.1038/nm.4236.
31. Mosele JI, Macià A, Motilva MJ. Metabolic and microbial modulation of the large intestine ecosystem by non-absorbed diet phenolic compounds: a review. Molecules. 2015;20:17429-17468. doi: 10.3390/molecules200917429.
32. den Besten G, van Eunen K, Groen AK, Venema K, Reijngoud DJ, Bakker BM. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54:2325-2340. doi: 10.1194/jlr.R036012.
33. Gao Z, Yin J, Zhang J, Ward RE, Martin RJ, Lefevre M, Cefalu WT, Ye J. Butyrate improves insulin sensitivity and increases energy expenditure in mice. Diabetes. 2009;58:1509-1517. doi: 10.2337/db08-1637.
34. De Vadder F, Kovatcheva-Datchary P, Goncalves D, Vinera J, Zitoun C, Duchampt A, Bäckhed F, Mithieux G. Microbiota-generated metabolites promote metabolic benefits via gut-brain neural circuits. Cell. 2014;156:84-96. doi: 10.1016/j.cell.2013.12.016.
35. den Besten G, Bleeker A, Gerding A, van Eunen K, Havinga R, van Dijk TH, Oosterveer MH, Jonker JW, Groen AK, Reijngoud DJ, Bakker BM. Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARγ-dependent switch from lipogenesis to fat oxidation. Diabetes. 2015;64:2398-2408. doi: 10.2337/db14-1213.
36. Kimura I, Ozawa K, Inoue D, Imamura T, Kimura K, Maeda T, Terasawa K, Kashihara D, Hirano K, Tani T, Takahashi T, Miyauchi S, Shioi G, Inoue H, Tsujimoto G. The gut microbiota suppresses insulin-mediated fat accumulation via the short-chain fatty acid receptor GPR43. Nat Commun. 2013;4:1829. doi: 10.1038/ncomms2852.
37. Frost G, Sleeth ML, Sahuri-Arisoylu M, et al. The short-chain fatty acid acetate reduces appetite via a central homeostatic mechanism. Nat Commun. 2014;5:3611. doi: 10.1038/ncomms4611.
38. Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI. Acetate mediates a microbiome-brain-β-cell axis to promote metabolic syndrome. Nature. 2016;534:213-217.
39. Natarajan N, Pluznick JL. From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology. Am J Physiol Cell Physiol. 2014;307:C979-C985. doi: 10.1152/ajpcell.00228.2014.
40. Maslowski KM, Vieira AT, Ng A, Kranich J, Sierro F, Yu D, Schilter HC, Rolph MS, Mackay F, Artis D, Xavier RJ, Teixeira MM, Mackay CR. Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43. Nature. 2009;461:1282-1286. doi: 10.1038/nature08530.
41. Andrade-Oliveira V, Amano MT, Correa-Costa M, et al. Gut bacteria products prevent AKI induced by ischemia-reperfusion. J Am Soc Nephrol. 2015;26:1877-1888. doi: 10.1681/ASN.2014030288.
42. Natarajan N, Hori D, Flavahan S, Steppan J, Flavahan NA, Berkowitz DE, Pluznick JL. Microbial short chain fatty acid metabolites lower blood pressure via endothelial G-protein coupled receptor 41. Physiol Genomics. 2016;48:826-834. doi: 10.1152/physiolgenomics.00089.2016.
43. Vinolo MA, Rodrigues HG, Hatanaka E, Sato FT, Sampaio SC, Curi R. Suppressive effect of short-chain fatty acids on production of proinflammatory mediators by neutrophils. J Nutr Biochem. 2011;22:849-855. doi: 10.1016/j.jnutbio.2010.07.009.
44. Morrison DJ, Preston T. Formation of short chain fatty acids by the gut microbiota and their impact on human metabolism. Gut Microbes. 2016;7:189-200. doi: 10.1080/19490976.2015.1134082.
45. Hanhineva K, Törrönen R, Bondia-Pons I, Pekkinen J, Kolehmainen M, Mykkänen H, Poutanen K. Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci. 2010;11:1365-1402. doi: 10.3390/ijms11041365.
46. Eid HM, Martineau LC, Saleem A, Muhammad A, Vallerand D, Benhaddou-Andaloussi A, Nistor L, Afshar A, Arnason JT, Haddad PS. Stimulation of AMP-activated protein kinase and enhancement of basal glucose uptake in muscle cells by quercetin and quercetin glycosides, active principles of the antidiabetic medicinal plant Vaccinium vitis-idaea. Mol Nutr Food Res. 2010;54:991-1003. doi: 10.1002/mnfr.200900218.
47. Kim MS, Hur HJ, Kwon DY, Hwang JT. Tangeretin stimulates glucose uptake via regulation of AMPK signaling pathways in C2C12 myotubes and improves glucose tolerance in high-fat diet-induced obese mice. Mol Cell Endocrinol. 2012;358:127-134. doi: 10.1016/j.mce.2012.03.013.
48. Ding L, Jin D, Chen X. Luteolin enhances insulin sensitivity via activation of PPARγ transcriptional activity in adipocytes. J Nutr Biochem. 2010;21:941-947. doi: 10.1016/j.jnutbio.2009.07.009.
49. Vazquez Prieto MA, Bettaieb A, Rodriguez Lanzi C, Soto VC, Perdicaro DJ, Galmarini CR, Haj FG, Miatello RM, Oteiza PI. Catechin and quercetin attenuate adipose inflammation in fructose-fed rats and 3T3-L1 adipocytes. Mol Nutr Food Res. 2015;59:622-633. doi: 10.1002/mnfr.201400631.
50. Goto T, Teraminami A, Lee JY, Ohyama K, Funakoshi K, Kim YI, Hirai S, Uemura T, Yu R, Takahashi N, Kawada T. Tiliroside, a glycosidic flavonoid, ameliorates obesity-induced metabolic disorders via activation of adiponectin signaling followed by enhancement of fatty acid oxidation in liver and skeletal muscle in obese-diabetic mice. J Nutr Biochem. 2012;23:768-776. doi: 10.1016/j.jnutbio.2011.04.001.
51. Li Z, Xu J, Zheng P, Xing L, Shen H, Yang L, Zhang L, Ji G. Hawthorn leaf flavonoids alleviate nonalcoholic fatty liver disease by enhancing the adiponectin/AMPK pathway. Int J Clin Exp Med. 2015;8:17295-17307.
52. Lin CL, Huang HC, Lin JK. Theaflavins attenuate hepatic lipid accumulation through activating AMPK in human HepG2 cells. J Lipid Res. 2007;48:2334-2343. doi: 10.1194/jlr.M700128-JLR200.
53. Rodriguez-Ramiro I, Vauzour D, Minihane AM. Polyphenols and nonalcoholic fatty liver disease: impact and mechanisms. Proc Nutr Soc. 2016;75:47-60.
54. Assini JM, Mulvihill EE, Sutherland BG, Telford DE, Sawyez CG, Felder SL, Chhoker S, Edwards JY, Gros R, Huff MW. Naringenin prevents cholesterolinduced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr-/- mice. J Lipid Res. 2013;54:711-724. doi: 10.1194/jlr.M032631.
55. Cai EP, Lin JK. Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agric Food Chem. 2009;57:9817-9827. doi: 10.1021/jf902618v.
56. Dai X, Ding Y, Zhang Z, Cai X, Li Y. Quercetin and quercitrin protect against cytokine-induced injuries in RINm5F β-cells via the mitochondrial pathway and NF-κB signaling. Int J Mol Med. 2013;31:265-271. doi: 10.3892/ijmm.2012.1177.
57. Fu Z, Zhang W, Zhen W, Lum H, Nadler J, Bassaganya-Riera J, Jia Z, Wang Y, Misra H, Liu D. Genistein induces pancreatic beta-cell proliferation through activation of multiple signaling pathways and prevents insulin-deficient diabetes in mice. Endocrinology. 2010;151:3026-3037. doi: 10.1210/en.2009-1294.
58. Bardy G, Virsolvy A, Quignard JF, Ravier MA, Bertrand G, Dalle S, Cros G, Magous R, Richard S, Oiry C. Quercetin induces insulin secretion by direct activation of L-type calcium channels in pancreatic beta cells. Br J Pharmacol. 2013;169:1102-1113. doi: 10.1111/bph.12194.
59. Kappel VD, Frederico MJ, Postal BG, Mendes CP, Cazarolli LH, Silva FR. The role of calcium in intracellular pathways of rutin in rat pancreatic islets: potential insulin secretagogue effect. Eur J Pharmacol. 2013;702:264-268. doi: 10.1016/j.ejphar.2013.01.055.
60. Clark JL, Zahradka P, Taylor CG. Efficacy of flavonoids in the management of high blood pressure. Nutr Rev. 2015;73:799-822. doi: 10.1093/nutrit/nuv048.
61. Li PG, Sun L, Han X, Ling S, Gan WT, Xu JW. Quercetin induces rapid eNOS phosphorylation and vasodilation by an Akt-independent and PKA-dependent mechanism. Pharmacology. 2012;89:220-228. doi: 10.1159/000337182.
62. Olaleye MT, Crown OO, Akinmoladun AC, Akindahunsi AA. Rutin and quercetin show greater efficacy than nifedipin in ameliorating hemodynamic, redox, and metabolite imbalances in sodium chlorideinduced hypertensive rats. Hum Exp Toxicol. 2014;33:602-608. doi: 10.1177/0960327113504790.
63. Rivera L, Morón R, Sánchez M, Zarzuelo A, Galisteo M. Quercetin ameliorates metabolic syndrome and improves the inflammatory status in obese Zucker rats. Obesity (Silver Spring). 2008;16:2081-2087. doi: 10.1038/oby.2008.315.
64. Croft KD. Dietary polyphenols: antioxidants or not? Arch Biochem Biophys. 2016;595:120-124. doi: 10.1016/j.abb.2015.11.014.
65. Kukongviriyapan U, Sompamit K, Pannangpetch P, Kukongviriyapan V, Donpunha W. Preventive and therapeutic effects of quercetin on lipopolysaccharide-induced oxidative stress and vascular dysfunction in mice. Can J Physiol Pharmacol. 2012;90:1345-1353. doi: 10.1139/y2012-101.
66. Liu PL, Liu JT, Kuo HF, Chong IW, Hsieh CC. Epigallocatechin gallate attenuates proliferation and oxidative stress in human vascular smooth muscle cells induced by interleukin-1β via heme oxygenase-1. Mediators Inflamm. 2014;2014:523684. doi: 10.1155/2014/523684.
67. Xu C, Chen J, Zhang J, Hu X, Zhou X, Lu Z, Jiang H. Naringenin inhibits angiotensin II-induced vascular smooth muscle cells proliferation and migration and decreases neointimal hyperplasia in balloon injured rat carotid arteries through suppressing oxidative stress. Biol Pharm Bull. 2013;36:1549-1555.
68. Fusi F, Spiga O, Trezza A, Sgaragli G, Saponara S. The surge of flavonoids as novel, fine regulators of cardiovascular Cav channels. Eur J Pharmacol. 2017;796:158-174. doi: 10.1016/j.ejphar.2016.12.033.
69. Mulvihill EE, Allister EM, Sutherland BG, Telford DE, Sawyez CG, Edwards JY, Markle JM, Hegele RA, Huff MW. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance. Diabetes. 2009;58:2198-2210. doi: 10.2337/db09-0634.
70. Hoek-van den Hil EF, van Schothorst EM, van der Stelt I, Swarts HJ, Venema D, Sailer M, Vervoort JJ, Hollman PC, Rietjens IM, Keijer J. Quercetin decreases high-fat diet induced body weight gain and accumulation of hepatic and circulating lipids in mice. Genes Nutr. 2014;9:418. doi: 10.1007/s12263-014-0418-2.
71. Tsutsumi R, Yoshida T, Nii Y, Okahisa N, Iwata S, Tsukayama M, Hashimoto R, Taniguchi Y, Sakaue H, Hosaka T, Shuto E, Sakai T. Sudachitin, a polymethoxylated flavone, improves glucose and lipid metabolism by increasing mitochondrial biogenesis in skeletal muscle. Nutr Metab (Lond). 2014;11:32. doi: 10.1186/1743-7075-11-32.
72. Zhang X, Zhang QX, Wang X, Zhang L, Qu W, Bao B, Liu CA, Liu J. Dietary luteolin activates browning and thermogenesis in mice through an AMPK/PGC1α pathway-mediated mechanism. Int J Obes (Lond). 2016;40:1841-1849. doi: 10.1038/ijo.2016.108.
73. Choi JH, Yun JW. Chrysin induces brown fat-like phenotype and enhances lipid metabolism in 3T3-L1 adipocytes. Nutrition. 2016;32:1002-1010. doi: 10.1016/j.nut.2016.02.007.
74. Kamio N, Suzuki T, Watanabe Y, Suhara Y, Osakabe N. A single oral dose of flavan-3-ols enhances energy expenditure by sympathetic nerve stimulation in mice. Free Radic Biol Med. 2016;91:256-263. doi: 10.1016/j. freeradbiomed.2015.12.030.
75. Watanabe N, Inagawa K, Shibata M, Osakabe N. Flavan-3-ol fraction from cocoa powder promotes mitochondrial biogenesis in skeletal muscle in mice. Lipids Health Dis. 2014;13:64. doi: 10.1186/1476-511X-13-64.
76. Okla M, Kang I, Kim DM, Gourineni V, Shay N, Gu L, Chung S. Ellagic acid modulates lipid accumulation in primary human adipocytes and human hepatoma Huh7 cells via discrete mechanisms. J Nutr Biochem. 2015;26:82-90. doi: 10.1016/j.jnutbio.2014.09.010.
77. Murase T, Misawa K, Minegishi Y, Aoki M, Ominami H, Suzuki Y, Shibuya Y, Hase T. Coffee polyphenols suppress diet-induced body fat accumulation by downregulating SREBP-1c and related molecules in C57BL/6J mice. Am J Physiol Endocrinol Metab. 2011;300:E122-E133. doi: 10.1152/ajpendo.00441.2010.
78. Tung YC, Li S, Huang Q, Hung WL, Ho CT, Wei GJ, Pan MH. 5-Demethylnobiletin and 5-acetoxy-6,7,8,3′,4′-pentamethoxyflavone suppress lipid accumulation by activating the LKB1-AMPK pathway in 3T3-L1 preadipocytes and high fat diet-fed C57BL/6 mice. J Agric Food Chem. 2016;64:3196-3205. doi: 10.1021/acs.jafc.6b00706.
79. Dong J, Zhang X, Zhang L, Bian HX, Xu N, Bao B, Liu J. Quercetin reduces obesity-associated ATM infiltration and inflammation in mice: a mechanism including AMPKα1/SIRT1. J Lipid Res. 2014;55:363-374. doi: 10.1194/jlr.M038786.
80. Lv D, Cheng X, Tang L, Jiang M. The cardioprotective effect of total flavonoids on myocardial ischemia/reperfusion in rats. Biomed Pharmacother. 2017;88:277-284. doi: 10.1016/j.biopha.2017.01.060.
81. Mantawy EM, El-Bakly WM, Esmat A, Badr AM, El-Demerdash E. Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur J Pharmacol. 2014;728:107-118. doi: 10.1016/j.ejphar.2014.01.065.
82. Prince PD, Fischerman L, Toblli JE, Fraga CG, Galleano M. LPS-induced renal inflammation is prevented by (-)-epicatechin in rats. Redox Biol. 2017;11:342-349. doi: 10.1016/j.redox.2016.12.023.
83. Rani N, Bharti S, Bhatia J, Nag TC, Ray R, Arya DS. Chrysin, a PPAR-γ agonist improves myocardial injury in diabetic rats through inhibiting AGE-RAGE mediated oxidative stress and inflammation. Chem Biol Interact. 2016;250:59-67. doi: 10.1016/j.cbi.2016.03.015.
84. Yuan X, Niu HT, Wang PL, Lu J, Zhao H, Liu SH, Zheng QS, Li CG. Cardioprotective effect of licochalcone D against myocardial ischemia/reperfusion injury in langendorff-perfused rat hearts. PLoS One. 2015;10:e0128375. doi: 10.1371/journal.pone.0128375.
85. Zempo H, Suzuki J, Watanabe R, Wakayama K, Kumagai H, Ikeda Y, Akazawa H, Komuro I, Isobe M. Cacao polyphenols ameliorate autoimmune myocarditis in mice. Hypertens Res. 2016;39:203-209. doi: 10.1038/hr.2015.136.
86. Erlejman AG, Jaggers G, Fraga CG, Oteiza PI. TNFalpha-induced NFkappaB activation and cell oxidant production are modulated by hexameric procyanidins in Caco-2 cells. Arch Biochem Biophys. 2008;476:186-195. doi: 10.1016/j.abb.2008.01.024.
87. Corti R, Flammer AJ, Hollenberg NK, Lüscher TF. Cocoa and cardiovascular health. Circulation. 2009;119:1433-1441. doi: 10.1161/CIRCULATIONAHA.108.827022.
88. Hooper L, Kay C, Abdelhamid A, Kroon PA, Cohn JS, Rimm EB, Cassidy A. Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: a systematic review and meta-analysis of randomized trials. Am J Clin Nutr. 2012;95:740-751. doi: 10.3945/ajcn.111.023457.
89. Shrime MG, Bauer SR, McDonald AC, Chowdhury NH, Coltart CE, Ding EL. Flavonoid-rich cocoa consumption affects multiple cardiovascular risk factors in a meta-analysis of short-term studies. J Nutr. 2011;141:1982-1988. doi: 10.3945/jn.111.145482.
90. Taubert D, Roesen R, Lehmann C, Jung N, Schömig E. Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: a randomized controlled trial. JAMA. 2007;298:49-60. doi: 10.1001/jama.298.1.49.
91. Yarmolinsky J, Gon G, Edwards P. Effect of tea on blood pressure for secondary prevention of cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials. Nutr Rev. 2015;73:236-246. doi: 10.1093/nutrit/nuv001.
92. Huang H, Chen G, Liao D, Zhu Y, Xue X. Effects of berries consumption on cardiovascular risk factors: a meta-analysis with trial sequential analysis of randomized controlled trials. Sci Rep. 2016;6:23625. doi: 10.1038/srep23625.
93. Jacques PF, Cassidy A, Rogers G, Peterson JJ, Meigs JB, Dwyer JT. Higher dietary flavonol intake is associated with lower incidence of type 2 diabetes. J Nutr. 2013;143:1474-1480. doi: 10.3945/jn.113.177212.
94. Cassidy A, Mukamal KJ, Liu L, Franz M, Eliassen AH, Rimm EB. High anthocyanin intake is associated with a reduced risk of myocardial infarction in young and middle-aged women. Circulation. 2013;127:188-196. doi: 10.1161/CIRCULATIONAHA.112.122408.
95. Cassidy A, Bertoia M, Chiuve S, Flint A, Forman J, Rimm EB. Habitual intake of anthocyanins and flavanones and risk of cardiovascular disease in men. Am J Clin Nutr. 2016;104:587-594. doi: 10.3945/ajcn.116.133132.
96. Goetz ME, Judd SE, Hartman TJ, McClellan W, Anderson A, Vaccarino V. Flavanone intake is inversely associated with risk of incident ischemic stroke in the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. J Nutr. 2016;146:2233-2243. doi: 10.3945/jn.116.230185.
97. Goetz ME, Judd SE, Safford MM, Hartman TJ, McClellan WM, Vaccarino V. Dietary flavonoid intake and incident coronary heart disease: the REasons for Geographic and Racial Differences in Stroke (REGARDS) study. Am J Clin Nutr. 2016;104:1236-1244. doi: 10.3945/ajcn.115.129452.
98. Buitrago-Lopez A, Sanderson J, Johnson L, Warnakula S, Wood A, Di Angelantonio E, Franco OH. Chocolate consumption and cardiometabolic disorders: systematic review and meta-analysis. BMJ. 2011;343:d4488.
99. Guo X, Yang B, Tan J, Jiang J, Li D. Associations of dietary intakes of anthocyanins and berry fruits with risk of type 2 diabetes mellitus: a systematic review and meta-analysis of prospective cohort studies. Eur J Clin Nutr. 2016;70:1360-1367. doi: 10.1038/ejcn.2016.142.
100. Zamora-Ros R, Touillaud M, Rothwell JA, Romieu I, Scalbert A. Measuring exposure to the polyphenol metabolome in observational epidemiologic studies: current tools and applications and their limits. Am J Clin Nutr. 2014;100:11-26. doi: 10.3945/ajcn.113.077743.
101. Rienks J, Barbaresko J, Nöthlings U. Association of isoflavone biomarkers with risk of chronic disease and mortality: a systematic review and meta-analysis of observational studies. Nutr Rev. 2017;75:616-641. doi: 10.1093/nutrit/nux021.
102. Bredsdorff L, Obel T, Dethlefsen C, Tjønneland A, Schmidt EB, Rasmussen SE, Overvad K. Urinary flavonoid excretion and risk of acute coronary syndrome in a nested case-control study. Am J Clin Nutr. 2013;98:209-216. doi: 10.3945/ajcn.112.046169.
103. Sun Q, Wedick NM, Tworoger SS, Pan A, Townsend MK, Cassidy A, Franke AA, Rimm EB, Hu FB, van Dam RM. Urinary excretion of select dietary polyphenol metabolites is associated with a lower risk of type 2 diabetes in proximate but not remote follow-up in a prospective investigation in 2 cohorts of US women. J Nutr. 2015;145:1280-1288. doi: 10.3945/jn.114.208736.
104. Yu D, Shu XO, Li H, Yang G, Cai Q, Xiang YB, Ji BT, Franke AA, Gao YT, Zheng W, Zhang X. Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in women. Am J Clin Nutr. 2015;102:680-686. doi: 10.3945/ajcn.115.111591.
105. Zhang X, Gao YT, Yang G, Li H, Cai Q, Xiang YB, Ji BT, Franke AA, Zheng W, Shu XO. Urinary isoflavonoids and risk of coronary heart disease. Int J Epidemiol. 2012;41:1367-1375. doi: 10.1093/ije/dys130.
106. Casas R, Sacanella E, Urpí-Sardà M, Chiva-Blanch G, Ros E, Martínez-González MA, Covas MI, Salas-Salvadó J, Fiol M, Arós F, Estruch R; Rosa Ma Lamuela-Raventos. The effects of the mediterranean diet on biomarkers of vascular wall inflammation and plaque vulnerability in subjects with high risk for cardiovascular disease. A randomized trial. PLoS One. 2014;9:e100084. doi: 10.1371/journal.pone.0100084.
107. Casas R, Sacanella E, Urpí-Sardà M, Corella D, Castañer O, Lamuela-Raventos RM, Salas-Salvadó J, Martínez-González MA, Ros E, Estruch R. Long-term immunomodulatory effects of a Mediterranean diet in adults at high risk of cardiovascular disease in the PREvención con DIeta MEDiterránea (PREDIMED) randomized controlled trial. J Nutr. 2016;146:1684-1693. doi: 10.3945/jn.115.229476.
108. Hernaez A, Castaner O, Goday A, et al. The Mediterranean diet decreases LDL atherogenicity in high cardiovascular risk individuals: a randomized controlled trial. Mol Nutr Food Res. 2017;61.
109. Estruch R, Ros E, Salas-Salvadó J, et al; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med. 2013;368:1279-1290. doi: 10.1056/NEJMoa1200303.
110. Estruch R, Martínez-González MA, Corella D, et al; PREDIMED Study Investigators. Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial. Lancet Diabetes Endocrinol. 2016;4:666-676. doi: 10.1016/S2213-8587(16)30085-7.
111. Aune D, Keum N, Giovannucci E, Fadnes LT, Boffetta P, Greenwood DC, Tonstad S, Vatten LJ, Riboli E, Norat T. Nut consumption and risk of cardiovascular disease, total cancer, all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis of prospective studies. BMC Med. 2016;14:207. doi: 10.1186/s12916-016-0730-3.
112. National Research Council (US) Committee on Technological Options to Improve the Nutritional Attributes of Animal Products. Current trends in consumption of animal products. In: Designing Foods: Animal Product Options in the Marketplace. Washington, DC: National Academies Press (US); 1988:18-44.
113. Dietary Guidelines Advisory Committee. Scientific Report of the 2015 Dietary Guidelines Advisory Committee. 2015;2015. https://health.gov/dietaryguidelines/2015-scientific-report/.
114. Leung PS. The potential protective action of vitamin D in hepatic insulin resistance and pancreatic islet dysfunction in type 2 diabetes mellitus. Nutrients. 2016;8:147. doi: 10.3390/nu8030147.
115. Muscogiuri G, Annweiler C, Duval G, Karras S, Tirabassi G, Salvio G, Balercia G, Kimball S, Kotsa K, Mascitelli L, Bhattoa HP, Colao A. Vitamin D and cardiovascular disease: from atherosclerosis to myocardial infarction and stroke. Int J Cardiol. 2017;230:577-584. doi: 10.1016/j. ijcard.2016.12.053.
116. Conceição EP, Moura EG, Soares PN, Ai XX, Figueiredo MS, Oliveira E, Lisboa PC. High calcium diet improves the liver oxidative stress and microsteatosis in adult obese rats that were overfed during lactation. Food Chem Toxicol. 2016;92:245-255. doi: 10.1016/j.fct.2016.04.015.
117. Sun X, Zemel MB. Dietary calcium regulates ROS production in aP2-agouti transgenic mice on high-fat/high-sucrose diets. Int J Obes (Lond). 2006;30:1341-1346. doi: 10.1038/sj.ijo.0803294.
118. Nobre JL, Lisboa PC, Lima Nda S, Franco JG, Nogueira Neto JF, de Moura EG, de Oliveira E. Calcium supplementation prevents obesity, hyperleptinaemia and hyperglycaemia in adult rats programmed by early weaning. Br J Nutr. 2012;107:979-988. doi: 10.1017/S0007114511003928.
119. Conceição EPS, Moura EG, Oliveira E, Guarda DS, Figueiredo MS, Quitete FT, Calvino C, Miranda RA, Mathias PCF, Manhães AC, Lisboa PC. Dietary calcium supplementation in adult rats reverts brown adipose tissue dysfunction programmed by postnatal early overfeeding. J Nutr Biochem. 2017;39:117-125. doi: 10.1016/j.jnutbio.2016.09.013.
120. Quitete FT, Nobre JL, Peixoto-Silva N, de Moura EG, Lisboa PC, de Oliveira E. Anti-obesogenic effects of calcium prevent changes in the GLP-1 profile in adult rats primed by early weaning. Mol Nutr Food Res. 2015;59:773-783. doi: 10.1002/mnfr.201400666.
121. Sun X, Zemel MB. Calcium and 1,25-dihydroxyvitamin D3 regulation of adipokine expression. Obesity (Silver Spring). 2007;15:340-348. doi: 10.1038/oby.2007.540.
122. Sun X, Zemel MB. Calcitriol and calcium regulate cytokine production and adipocyte-macrophage cross-talk. J Nutr Biochem. 2008;19:392-399. doi: 10.1016/j.jnutbio.2007.05.013.
123. Chaplin A, Parra P, Laraichi S, Serra F, Palou A. Calcium supplementation modulates gut microbiota in a prebiotic manner in dietary obese mice. Mol Nutr Food Res. 2016;60:468-480. doi: 10.1002/mnfr.201500480.
124. Gomes JM, Costa JA, Alfenas RC. Could the beneficial effects of dietary calcium on obesity and diabetes control be mediated by changes in intestinal microbiota and integrity? Br J Nutr. 2015;114:1756-1765. doi: 10.1017/S0007114515003608.
125. de Wit NJ, Bosch-Vermeulen H, Oosterink E, Müller M, van der Meer R. Supplementary dietary calcium stimulates faecal fat and bile acid excretion, but does not protect against obesity and insulin resistance in C57BL/6J mice. Br J Nutr. 2011;105:1005-1011. doi: 10.1017/S0007114510004654.
126. Thomas AP, Dunn TN, Drayton JB, Oort PJ, Adams SH. A high calcium diet containing nonfat dry milk reduces weight gain and associated adipose tissue inflammation in diet-induced obese mice when compared to high calcium alone. Nutr Metab (Lond). 2012;9:3. doi: 10.1186/1743-7075-9-3.
127. Thomas AP, Dunn TN, Drayton JB, Oort PJ, Adams SH. A dairybased high calcium diet improves glucose homeostasis and reduces steatosis in the context of preexisting obesity. Obesity (Silver Spring). 2013;21:E229-E235. doi: 10.1002/oby.20039.
128. Booth AO, Huggins CE, Wattanapenpaiboon N, Nowson CA. Effect of increasing dietary calcium through supplements and dairy food on body weight and body composition: a meta-analysis of randomised controlled trials. Br J Nutr. 2015;114:1013-1025. doi: 10.1017/S0007114515001518.
129. Cormick G, Ciapponi A, Cafferata ML, Belizan JM. Calcium supplementation for prevention of primary hypertension. Cochrane Database Syst Rev. 2015:CD010037.
130. Jolma P, Kalliovalkama J, Tolvanen JP, Kööbi P, Kähönen M, Hutri-Kähönen N, Wu X, Pörsti I. High-calcium diet enhances vasorelaxation in nitric oxide-deficient hypertension. Am J Physiol Heart Circ Physiol. 2000;279:H1036-H1043. doi: 10.1152/ajpheart.2000.279.3.H1036.
131. Mäkynen H, Kähönen M, Wu X, Arvola P, Pörsti I. Endothelial function in deoxycorticosterone-NaCl hypertension: effect of calcium supplementation. Circulation. 1996;93:1000-1008.
132. McCarron DA, Lucas PA, Shneidman RJ, LaCour B, Drüeke T. Blood pressure development of the spontaneously hypertensive rat after concurrent manipulations of dietary Ca2+ and Na+. Relation to intestinal Ca2+ fluxes. J Clin Invest. 1985;76:1147-1154. doi: 10.1172/JCI112070.
133. Pörsti I, Fan M, Kööbi P, Jolma P, Kalliovalkama J, Vehmas TI, Helin H, Holthöfer H, Mervaala E, Nyman T, Tikkanen I. High calcium diet down-regulates kidney angiotensin-converting enzyme in experimental renal failure. Kidney Int. 2004;66:2155-2166. doi: 10.1111/j.1523-1755.2004.66006.x.
134. Bolland MJ, Grey A, Avenell A, Gamble GD, Reid IR. Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis. BMJ. 2011;342:d2040.
135. Mao PJ, Zhang C, Tang L, Xian YQ, Li YS, Wang WD, Zhu XH, Qiu HL, He J, Zhou YH. Effect of calcium or vitamin D supplementation on vascular outcomes: a meta-analysis of randomized controlled trials. Int J Cardiol. 2013;169:106-111. doi: 10.1016/j.ijcard.2013.08.055.
136. Larsson SC, Burgess S, Michaëlsson K. Association of genetic variants related to serum calcium levels with coronary artery disease and myocardial infarction. JAMA. 2017;318:371-380. doi: 10.1001/jama.2017.8981.
137. Fekete AA, Givens DI, Lovegrove JA. Can milk proteins be a useful tool in the management of cardiometabolic health? An updated review of human intervention trials. Proc Nutr Soc. 2016;75:328-341.
138. Healy NP, Kirwan AM, McArdle MA, et al. A casein hydrolysate protects mice against high fat diet induced hyperglycemia by attenuating NLRP3 inflammasome-mediated inflammation and improving insulin signaling. Mol Nutr Food Res. 2016;60:2421-2432. doi: 10.1002/mnfr.201501054.
139. Pezeshki A, Fahim A, Chelikani PK. Dietary whey and casein differentially affect energy balance, gut hormones, glucose metabolism, and taste preference in diet-induced obese rats. J Nutr. 2015;145:2236-2244. doi: 10.3945/jn.115.213843.
140. Singh A, Pezeshki A, Zapata RC, Yee NJ, Knight CG, Tuor UI, Chelikani PK. Diets enriched in whey or casein improve energy balance and prevent morbidity and renal damage in salt-loaded and high-fat-fed spontaneously hypertensive stroke-prone rats. J Nutr Biochem. 2016;37:47-59. doi: 10.1016/j.jnutbio.2016.07.011.
141. Li H, Xu M, Lee J, He C, Xie Z. Leucine supplementation increases SIRT1 expression and prevents mitochondrial dysfunction and metabolic disorders in high-fat diet-induced obese mice. Am J Physiol Endocrinol Metab. 2012;303:E1234-E1244. doi: 10.1152/ajpendo.00198.2012.
142. Ren M, Zhang S, Liu X, Li S, Mao X, Zeng X, Qiao S. Different lipopolysaccharide branched-chain amino acids modulate porcine intestinal endogenous β-defensin expression through the Sirt1/ERK/90RSK pathway. J Agric Food Chem. 2016;64:3371-3379. doi: 10.1021/acs. jafc.6b00968.
143. Jakubowicz D, Froy O. Biochemical and metabolic mechanisms by which dietary whey protein may combat obesity and type 2 diabetes. J Nutr Biochem. 2013;24:1-5. doi: 10.1016/j.jnutbio.2012.07.008.
144. Tong X, Li W, Xu JY, Han S, Qin LQ. Effects of whey protein and leucine supplementation on insulin resistance in non-obese insulin-resistant model rats. Nutrition. 2014;30:1076-1080. doi: 10.1016/j.nut.2014.01.013.
145. Newgard CB, An J, Bain JR, et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 2009;9:311-326. doi: 10.1016/j.cmet.2009.02.002.
146. Zhenyukh O, Civantos E, Ruiz-Ortega M, Sánchez MS, Vázquez C, Peiró C, Egido J, Mas S. High concentration of branched-chain amino acids promotes oxidative stress, inflammation and migration of human peripheral blood mononuclear cells via mTORC1 activation. Free Radic Biol Med. 2017;104:165-177. doi: 10.1016/j.freeradbiomed.2017.01.009.
147. Pedroso JA, Zampieri TT, Donato J Jr. Reviewing the effects of L-leucine supplementation in the regulation of food intake, energy balance, and glucose homeostasis. Nutrients. 2015;7:3914-3937. doi: 10.3390/nu7053914.
148. Fekete ÁA, Givens DI, Lovegrove JA. The impact of milk proteins and peptides on blood pressure and vascular function: a review of evidence from human intervention studies. Nutr Res Rev. 2013;26:177-190. doi: 10.1017/S0954422413000139.
149. Fekete ÁA, Givens DI, Lovegrove JA. Casein-derived lactotripeptides reduce systolic and diastolic blood pressure in a meta-analysis of randomised clinical trials. Nutrients. 2015;7:659-681. doi: 10.3390/nu7010659.
150. Capriotti AL, Cavaliere C, Piovesana S, Samperi R, Laganà A. Recent trends in the analysis of bioactive peptides in milk and dairy products. Anal Bioanal Chem. 2016;408:2677-2685. doi: 10.1007/s00216-016-9303-8.
151. Jäkälä P, Vapaatalo H. Antihypertensive peptides from milk proteins. Pharmaceuticals (Basel). 2010;3:251-272. doi: 10.3390/ph3010251.
152. Zhang Y, Chen R, Ma H, Chen S. Isolation and identification of dipeptidyl peptidase IV-inhibitory peptides from trypsin/chymotrypsin-treated goat milk casein hydrolysates by 2D-TLC and LC-MS/MS. J Agric Food Chem. 2015;63:8819-8828. doi: 10.1021/acs.jafc.5b03062.
153. Tulipano G, Sibilia V, Caroli AM, Cocchi D. Whey proteins as source of dipeptidyl dipeptidase IV (dipeptidyl peptidase-4) inhibitors. Peptides. 2011;32:835-838. doi: 10.1016/j.peptides.2011.01.002.
154. Foltz M, van der Pijl PC, Duchateau GS. Current in vitro testing of bioactive peptides is not valuable. J Nutr. 2010;140:117-118. doi: 10.3945/jn.109.116228.
155. Micha R, Mozaffarian D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence. Lipids. 2010;45:893-905. doi: 10.1007/s11745-010-3393-4.
156. Markiewicz-Keszycka M, Czyzak-Runowska G, Lipinska P, Wojtowski J. Fatty acid profile of milk - a review. Bull Vet Inst Pulawy. 2013;57:135.
157. Mansson HL. Fatty acids in bovine milk fat. Food Nutr Res. 2008;52:1, 1821. doi: 10.3402/fnr.v52i0.1821.
158. Ran-Ressler RR, Bae S, Lawrence P, Wang DH, Brenna JT. Branchedchain fatty acid content of foods and estimated intake in the USA. Br J Nutr. 2014;112:565-572. doi: 10.1017/S0007114514001081.
159. Hommelberg PP, Plat J, Langen RC, Schols AM, Mensink RP. Fatty acid-induced NF-kappaB activation and insulin resistance in skeletal muscle are chain length dependent. Am J Physiol Endocrinol Metab. 2009;296:E114-E120. doi: 10.1152/ajpendo.00436.2007.
160. Montgomery MK, Osborne B, Brown SH, Small L, Mitchell TW, Cooney GJ, Turner N. Contrasting metabolic effects of medium-versus longchain fatty acids in skeletal muscle. J Lipid Res. 2013;54:3322-3333. doi: 10.1194/jlr.M040451.
161. Turner N, Hariharan K, TidAng J, Frangioudakis G, Beale SM, Wright LE, Zeng XY, Leslie SJ, Li JY, Kraegen EW, Cooney GJ, Ye JM. Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes. 2009;58:2547-2554. doi: 10.2337/db09-0784.
162. Chamma CM, Bargut TC, Mandarim-de-Lacerda CA, Aguila MB. A rich medium-chain triacylglycerol diet benefits adiposity but has adverse effects on the markers of hepatic lipogenesis and beta-oxidation. Food Funct. 2017;8:778-787. doi: 10.1039/c6fo01663d.
163. Bedi S, Hines GV, Lozada-Fernandez VV, de Jesus Piva C, Kaliappan A, Rider SD Jr, Hostetler HA. Fatty acid binding profile of the liver X receptor α. J Lipid Res. 2017;58:393-402. doi: 10.1194/jlr.M072447.
164. Mozaffarian D. Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health: the Ludwigshafen Risk and Cardiovascular Health Study. Eur Heart J. 2016;37:1079-1081. doi: 10.1093/eurheartj/ehv595.
165. Chan KL, Pillon NJ, Sivaloganathan DM, Costford SR, Liu Z, Théret M, Chazaud B, Klip A. Palmitoleate reverses high fat-induced proinflammatory macrophage polarization via AMP-activated protein kinase (AMPK). J Biol Chem. 2015;290:16979-16988. doi: 10.1074/jbc. M115.646992.
166. Duckett SK, Volpi-Lagreca G, Alende M, Long NM. Palmitoleic acid reduces intramuscular lipid and restores insulin sensitivity in obese sheep. Diabetes Metab Syndr Obes. 2014;7:553-563. doi: 10.2147/DMSO. S72695.
167. de Souza CO, Teixeira AAS, Biondo LA, Lima Junior EA, Batatinha HAP, Rosa Neto JC. Palmitoleic acid improves metabolic functions in fatty liver by PPARα-dependent AMPK activation. J Cell Physiol. 2017;232:2168-2177. doi: 10.1002/jcp.25715.
168. Souza CO, Teixeira AA, Lima EA, Batatinha HA, Gomes LM, Carvalho-Silva M, Mota IT, Streck EL, Hirabara SM, Rosa Neto JC. Palmitoleic acid (n-7) attenuates the immunometabolic disturbances caused by a high-fat diet independently of PPARα. Mediators Inflamm. 2014;2014:582197. doi: 10.1155/2014/582197.
169. Talbot NA, Wheeler-Jones CP, Cleasby ME. Palmitoleic acid prevents palmitic acid-induced macrophage activation and consequent p38 MAPK-mediated skeletal muscle insulin resistance. Mol Cell Endocrinol. 2014;393:129-142. doi: 10.1016/j.mce.2014.06.010.
170. Bernstein AM, Roizen MF, Martinez L. Purified palmitoleic acid for the reduction of high-sensitivity C-reactive protein and serum lipids: a double-blinded, randomized, placebo controlled study. J Clin Lipidol. 2014;8:612-617. doi: 10.1016/j.jacl.2014.08.001.
171. Kraft J, Jetton T, Satish B, Gupta D. Dairy-derived bioactive fatty acids improve pancreatic ß-cell function. FASEB J. 2015;29:608.25.
172. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease: effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol. 2011;58:2047-2067. doi: 10.1016/j.jacc.2011.06.063.
173. Hodson L, Eyles HC, McLachlan KJ, Bell ML, Green TJ, Skeaff CM. Plasma and erythrocyte fatty acids reflect intakes of saturated and n-6 PUFA within a similar time frame. J Nutr. 2014;144:33-41. doi: 10.3945/jn.113.183749.
174. Pfeuffer M, Jaudszus A. Pentadecanoic and heptadecanoic acids: multifaceted odd-chain fatty acids. Adv Nutr. 2016;7:730-734. doi: 10.3945/an.115.011387.
175. Arranz E, Corredig M. Invited review: milk phospholipid vesicles, their colloidal properties, and potential as delivery vehicles for bioactive molecules. J Dairy Sci. 2017;100:4213-4222. doi: 10.3168/jds.2016-12236.
176. Chung RW, Kamili A, Tandy S, Weir JM, Gaire R, Wong G, Meikle PJ, Cohn JS, Rye KA. Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice. PLoS One. 2013;8:e55949. doi: 10.1371/journal.pone.0055949.
177. Kamili A, Wat E, Chung RW, Tandy S, Weir JM, Meikle PJ, Cohn JS. Hepatic accumulation of intestinal cholesterol is decreased and fecal cholesterol excretion is increased in mice fed a high-fat diet supplemented with milk phospholipids. Nutr Metab (Lond). 2010;7:90. doi: 10.1186/1743-7075-7-90.
178. Wat E, Tandy S, Kapera E, Kamili A, Chung RW, Brown A, Rowney M, Cohn JS. Dietary phospholipid-rich dairy milk extract reduces hepatomegaly, hepatic steatosis and hyperlipidemia in mice fed a high-fat diet. Atherosclerosis. 2009;205:144-150. doi: 10.1016/j. atherosclerosis.2008.12.004.
179. Snow DR, Ward RE, Olsen A, Jimenez-Flores R, Hintze KJ. Membranerich milk fat diet provides protection against gastrointestinal leakiness in mice treated with lipopolysaccharide. J Dairy Sci. 2011;94:2201-2212. doi: 10.3168/jds.2010-3886.
180. Rosqvist F, Smedman A, Lindmark-Månsson H, Paulsson M, Petrus P, Straniero S, Rudling M, Dahlman I, Risérus U. Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: a randomized study. Am J Clin Nutr. 2015;102:20-30. doi: 10.3945/ajcn.115.107045.
181. Hjerpsted J, Leedo E, Tholstrup T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am J Clin Nutr. 2011;94:1479-1484. doi: 10.3945/ajcn.111.022426.
182. Soerensen KV, Thorning TK, Astrup A, Kristensen M, Lorenzen JK. Effect of dairy calcium from cheese and milk on fecal fat excretion, blood lipids, and appetite in young men. Am J Clin Nutr. 2014;99:984-991. doi: 10.3945/ajcn.113.077735.
183. Guidelines for the Evaluation of Probiotics in Food. Report of a Joint FAO/WHO Working Group on Drafting Guidelines for the Evaluation of Probiotics in Food. London, Ontario. 2002. http://www.who.int/foodsafety/fs-management/en/probiotic-guidelines.pdf.
184. Kim DH, Kim H, Jeong D, Kang IB, Chon JW, Kim HS, Song KY, Seo KH. Kefir alleviates obesity and hepatic steatosis in high-fat dietfed mice by modulation of gut microbiota and mycobiota: targeted and untargeted community analysis with correlation of biomarkers. J Nutr Biochem. 2017;44:35-43. doi: 10.1016/j.jnutbio.2017.02.014.
185. Singh S, Sharma RK, Malhotra S, Pothuraju R, Shandilya UK. Lactobacillus rhamnosus NCDC17 ameliorates type-2 diabetes by improving gut function, oxidative stress and inflammation in high-fat-diet fed and streptozotocin-treated rats. Benef Microbes. 2017;8:243-255. doi: 10.3920/BM2016.0090.
186. Gerritsen J, Smidt H, Rijkers GT, de Vos WM. Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr. 2011;6:209-240. doi: 10.1007/s12263-011-0229-7.
187. de Moreno de Leblanc A, Perdigon G. The application of probiotic fermented milks in cancer and intestinal inflammation. Proc Nutr Soc. 2010;69:421-428.
188. Veiga P, Gallini CA, Beal C, Michaud M, Delaney ML, DuBois A, Khlebnikov A, van Hylckama Vlieg JE, Punit S, Glickman JN, Onderdonk A, Glimcher LH, Garrett WS. Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes. Proc Natl Acad Sci USA. 2010;107:18132-18137.
189. Bron PA, Kleerebezem M, Brummer RJ, Cani PD, Mercenier A, MacDonald TT, Garcia-Ródenas CL, Wells JM. Can probiotics modulate human disease by impacting intestinal barrier function? Br J Nutr. 2017;117:93-107. doi: 10.1017/S0007114516004037.
190. Shirouchi B, Nagao K, Umegatani M, Shiraishi A, Morita Y, Kai S, Yanagita T, Ogawa A, Kadooka Y, Sato M. Probiotic Lactobacillus gasseri SBT2055 improves glucose tolerance and reduces body weight gain in rats by stimulating energy expenditure. Br J Nutr. 2016;116:451-458. doi: 10.1017/S0007114516002245.
191. Yadav H, Lee JH, Lloyd J, Walter P, Rane SG. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. J Biol Chem. 2013;288:25088-25097. doi: 10.1074/jbc.M113.452516.
192. Barrett HL, Dekker Nitert M, Conwell LS, Callaway LK. Probiotics for preventing gestational diabetes. Cochrane Database Syst Rev. 2014:Cd009951.
193. Jung SP, Lee KM, Kang JH, Yun SI, Park HO, Moon Y, Kim JY. Effect of Lactobacillus gasseri BNR17 on overweight and obese adults: a randomized, double-blind clinical trial. Korean J Fam Med. 2013;34:80-89. doi: 10.4082/kjfm.2013.34.2.80.
194. Kadooka Y, Sato M, Imaizumi K, Ogawa A, Ikuyama K, Akai Y, Okano M, Kagoshima M, Tsuchida T. Regulation of abdominal adiposity by probiotics (Lactobacillus gasseri SBT2055) in adults with obese tendencies in a randomized controlled trial. Eur J Clin Nutr. 2010;64:636-643. doi: 10.1038/ejcn.2010.19.
195. Kadooka Y, Sato M, Ogawa A, Miyoshi M, Uenishi H, Ogawa H, Ikuyama K, Kagoshima M, Tsuchida T. Effect of Lactobacillus gasseri SBT2055 in fermented milk on abdominal adiposity in adults in a randomised controlled trial. Br J Nutr. 2013;110:1696-1703. doi: 10.1017/S0007114513001037.
196. Mozaffarian D, Hao T, Rimm EB, Willett WC, Hu FB. Changes in diet and lifestyle and long-term weight gain in women and men. N Engl J Med. 2011;364:2392-2404. doi: 10.1056/NEJMoa1014296.
197. Park DY, Ahn YT, Park SH, Huh CS, Yoo SR, Yu R, Sung MK, McGregor RA, Choi MS. Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity. PLoS One. 2013;8:e59470. doi: 10.1371/journal.pone.0059470.
198. Poutahidis T, Kleinewietfeld M, Smillie C, Levkovich T, Perrotta A, Bhela S, Varian BJ, Ibrahim YM, Lakritz JR, Kearney SM, Chatzigiagkos A, Hafler DA, Alm EJ, Erdman SE. Microbial reprogramming inhibits Western diet-associated obesity. PLoS One. 2013;8:e68596. doi: 10.1371/journal.pone.0068596.
199. Power SE, O'Toole PW, Stanton C, Ross RP, Fitzgerald GF. Intestinal microbiota, diet and health. Br J Nutr. 2014;111:387-402. doi: 10.1017/S0007114513002560.
200. Sanchez M, Darimont C, Drapeau V, et al. Effect of Lactobacillus rhamnosus CGMCC1.3724 supplementation on weight loss and maintenance in obese men and women. Br J Nutr. 2014;111:1507-1519. doi: 10.1017/S0007114513003875.
201. Sharafedtinov KK, Plotnikova OA, Alexeeva RI, Sentsova TB, Songisepp E, Stsepetova J, Smidt I, Mikelsaar M. Hypocaloric diet supplemented with probiotic cheese improves body mass index and blood pressure indices of obese hypertensive patients-a randomized double-blind placebo-controlled pilot study. Nutr J. 2013;12:138. doi: 10.1186/1475-2891-12-138.
202. Smith JD, Hou T, Ludwig DS, Rimm EB, Willett W, Hu FB, Mozaffarian D. Changes in intake of protein foods, carbohydrate amount and quality, and long-term weight change: results from 3 prospective cohorts. Am J Clin Nutr. 2015;101:1216-1224. doi: 10.3945/ajcn.114.100867.
203. Wang H, Troy LM, Rogers GT, Fox CS, McKeown NM, Meigs JB, Jacques PF. Longitudinal association between dairy consumption and changes of body weight and waist circumference: the Framingham Heart Study. Int J Obes (Lond). 2014;38:299-305. doi: 10.1038/ijo.2013.78.
204. Vermeer C. Vitamin K: the effect on health beyond coagulation - an overview. Food Nutr Res. 2012;56.
205. Walther B, Karl JP, Booth SL, Boyaval P. Menaquinones, bacteria, and the food supply: the relevance of dairy and fermented food products to vitamin K requirements. Adv Nutr. 2013;4:463-473. doi: 10.3945/an.113.003855.
206. Kanazawa I. Osteocalcin as a hormone regulating glucose metabolism. World J Diabetes. 2015;6:1345-1354. doi: 10.4239/wjd.v6.i18.1345.
207. Choi HJ, Yu J, Choi H, An JH, Kim SW, Park KS, Jang HC, Kim SY, Shin CS. Vitamin K2 supplementation improves insulin sensitivity via osteocalcin metabolism: a placebo-controlled trial. Diabetes Care. 2011;34:e147. doi: 10.2337/dc11-0551.
208. Rasekhi H, Karandish M, Jalali MT, Mohammad-Shahi M, Zarei M, Saki A, Shahbazian H. The effect of vitamin K1 supplementation on sensitivity and insulin resistance via osteocalcin in prediabetic women: a double-blind randomized controlled clinical trial. Eur J Clin Nutr. 2015;69:891-895. doi: 10.1038/ejcn.2015.17.
209. Kumar R, Binkley N, Vella A. Effect of phylloquinone supplementation on glucose homeostasis in humans. Am J Clin Nutr. 2010;92:1528-1532. doi: 10.3945/ajcn.2010.30108.
210. Manna P, Kalita J. Beneficial role of vitamin K supplementation on insulin sensitivity, glucose metabolism, and the reduced risk of type 2 diabetes: a review. Nutrition. 2016;32:732-739. doi: 10.1016/j.nut.2016.01.011.
211. Gundberg CM, Lian JB, Booth SL. Vitamin K-dependent carboxylation of osteocalcin: friend or foe? Adv Nutr. 2012;3:149-157. doi: 10.3945/an.112.001834.
212. Scheiber D, Veulemans V, Horn P, Chatrou ML, Potthoff SA, Kelm M, Schurgers LJ, Westenfeld R. High-dose menaquinone-7 supplementation reduces cardiovascular calcification in a murine model of extraosseous calcification. Nutrients. 2015;7:6991-7011. doi: 10.3390/nu7085318.
213. Schurgers LJ, Spronk HM, Soute BA, Schiffers PM, DeMey JG, Vermeer C. Regression of warfarin-induced medial elastocalcinosis by high intake of vitamin K in rats. Blood. 2007;109:2823-2831. doi: 10.1182/blood-2006-07-035345.
214. Spronk HM, Soute BA, Schurgers LJ, Thijssen HH, De Mey JG, Vermeer C. Tissue-specific utilization of menaquinone-4 results in the prevention of arterial calcification in warfarin-treated rats. J Vasc Res. 2003;40:531-537. doi: 10.1159/000075344.
215. Schurgers LJ, Vermeer C. Differential lipoprotein transport pathways of K-vitamins in healthy subjects. Biochim Biophys Acta. 2002;1570:27-32.
216. Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109:3279-3283. doi: 10.1182/blood-2006-08-040709.
217. Beulens JW, Bots ML, Atsma F, Bartelink ML, Prokop M, Geleijnse JM, Witteman JC, Grobbee DE, van der Schouw YT. High dietary menaquinone intake is associated with reduced coronary calcification. Atherosclerosis. 2009;203:489-493. doi: 10.1016/j.atherosclerosis.2008.07.010.
218. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, Hofman A, Witteman JC. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam study. J Nutr. 2004;134:3100-3105.
219. Gast GC, de Roos NM, Sluijs I, Bots ML, Beulens JW, Geleijnse JM, Witteman JC, Grobbee DE, Peeters PH, van der Schouw YT. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr Metab Cardiovasc Dis. 2009;19:504-510. doi: 10.1016/j. numecd.2008.10.004.
220. Chen M, Pan A, Malik VS, Hu FB. Effects of dairy intake on body weight and fat: a meta-analysis of randomized controlled trials. Am J Clin Nutr. 2012;96:735-747. doi: 10.3945/ajcn.112.037119.
221. Abargouei AS, Janghorbani M, Salehi-Marzijarani M, Esmaillzadeh A. Effect of dairy consumption on weight and body composition in adults: a systematic review and meta-analysis of randomized controlled clinical trials. Int J Obes (Lond). 2012;36:1485-1493. doi: 10.1038/ijo.2011.269.
222. Scharf RJ, Demmer RT, DeBoer MD. Longitudinal evaluation of milk type consumed and weight status in preschoolers. Arch Dis Child. 2013;98:335-340. doi: 10.1136/archdischild-2012-302941.
223. Noel SE, Ness AR, Northstone K, Emmett P, Newby PK. Associations between flavored milk consumption and changes in weight and body composition over time: differences among normal and overweight children. Eur J Clin Nutr. 2013;67:295-300. doi: 10.1038/ejcn.2012.123.
224. Huh SY, Rifas-Shiman SL, Rich-Edwards JW, Taveras EM, Gillman MW. Prospective association between milk intake and adiposity in preschool-aged children. J Am Diet Assoc. 2010;110:563-570. doi: 10.1016/j.jada.2009.12.025.
225. Berkey CS, Rockett HR, Willett WC, Colditz GA. Milk, dairy fat, dietary calcium, and weight gain: a longitudinal study of adolescents. Arch Pediatr Adolesc Med. 2005;159:543-550. doi: 10.1001/archpedi.159.6.543.
226. Noel SE, Ness AR, Northstone K, Emmett P, Newby PK. Milk intakes are not associated with percent body fat in children from ages 10 to 13 years. J Nutr. 2011;141:2035-2041. doi: 10.3945/jn.111.143420.
227. Niinikoski H, Viikari J, Rönnemaa T, Helenius H, Jokinen E, Lapinleimu H, Routi T, Lagström H, Seppänen R, Välimäki I, Simell O. Regulation of growth of 7- to 36-month-old children by energy and fat intake in the prospective, randomized STRIP baby trial. Pediatrics. 1997;100:810-816.
228. Nupponen M, Pahkala K, Juonala M, Magnussen CG, Niinikoski H, Rönnemaa T, Viikari JS, Saarinen M, Lagström H, Jula A, Simell O, Raitakari OT. Metabolic syndrome from adolescence to early adulthood: effect of infancy-onset dietary counseling of low saturated fat: the Special Turku Coronary Risk Factor Intervention Project (STRIP). Circulation. 2015;131:605-613. doi: 10.1161/CIRCULATIONAHA.114.010532.
229. Soedamah-Muthu SS, Verberne LD, Ding EL, Engberink MF, Geleijnse JM. Dairy consumption and incidence of hypertension: a dose-response meta-analysis of prospective cohort studies. Hypertension. 2012;60:1131-1137. doi: 10.1161/HYPERTENSIONAHA.112.195206.
230. Hu D, Huang J, Wang Y, Zhang D, Qu Y. Dairy foods and risk of stroke: a meta-analysis of prospective cohort studies. Nutr Metab Cardiovasc Dis. 2014;24:460-469. doi: 10.1016/j.numecd.2013.12.006.
231. Qin LQ, Xu JY, Han SF, Zhang ZL, Zhao YY, Szeto IM. Dairy consumption and risk of cardiovascular disease: an updated meta-analysis of prospective cohort studies. Asia Pac J Clin Nutr. 2015;24:90-100.
232. Gao D, Ning N, Wang C, Wang Y, Li Q, Meng Z, Liu Y, Li Q. Dairy products consumption and risk of type 2 diabetes: systematic review and dose-response meta-analysis. PLoS One. 2013;8:e73965. doi: 10.1371/journal.pone.0073965.
233. Aune D, Norat T, Romundstad P, Vatten LJ. Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies. Am J Clin Nutr. 2013;98:1066-1083. doi: 10.3945/ajcn.113.059030.
234. Sluijs I, Forouhi NG, Beulens JW, et al; InterAct Consortium. The amount and type of dairy product intake and incident type 2 diabetes: results from the EPIC-InterAct Study. Am J Clin Nutr. 2012;96:382-390. doi: 10.3945/ajcn.111.021907.
235. Chen M, Sun Q, Giovannucci E, Mozaffarian D, Manson JE, Willett WC, Hu FB. Dairy consumption and risk of type 2 diabetes: 3 cohorts of US adults and an updated meta-analysis. BMC Med. 2014;12:215. doi: 10.1186/s12916-014-0215-1.
236. Mensink RP, Zock PL, Kester AD, Katan MB. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr. 2003;77:1146-1155.
237. Thorning TK, Bertram HC, Bonjour JP, et al. Whole dairy matrix or single nutrients in assessment of health effects: current evidence and knowledge gaps. Am J Clin Nutr. 2017;105:1033-1045. doi: 10.3945/ajcn.116.151548.
238. Ericson U, Hellstrand S, Brunkwall L, Schulz CA, Sonestedt E, Wallström P, Gullberg B, Wirfält E, Orho-Melander M. Food sources of fat may clarify the inconsistent role of dietary fat intake for incidence of type 2 diabetes. Am J Clin Nutr. 2015;101:1065-1080. doi: 10.3945/ajcn.114.103010.
239. Diaz-Lopez A, Bullo M, Martinez-Gonzalez MA, et al. Dairy product consumption and risk of type 2 diabetes in an elderly Spanish Mediterranean population at high cardiovascular risk. Eur J Nutr. 2016;55:349-360. doi: 10.1007/s00394-015-0855-8.
240. Nestel PJ, Mellett N, Pally S, Wong G, Barlow CK, Croft K, Mori TA, Meikle PJ. Effects of low-fat or full-fat fermented and nonfermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br J Nutr. 2013;110:2242-2249. doi: 10.1017/S0007114513001621.
241. Mozaffarian D, Cao H, King IB, Lemaitre RN, Song X, Siscovick DS, Hotamisligil GS. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in U.S. adults: a cohort study. Ann Intern Med. 2010;153:790-799. doi: 10.7326/0003-4819-153-12-201012210-00005.
242. Mozaffarian D, de Oliveira Otto MC, Lemaitre RN, Fretts AM, Hotamisligil G, Tsai MY, Siscovick DS, Nettleton JA. trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr. 2013;97:854-861. doi: 10.3945/ajcn.112.045468.
243. Kratz M, Baars T, Guyenet S. The relationship between high-fat dairy consumption and obesity, cardiovascular, and metabolic disease. Eur J Nutr. 2013;52:1-24. doi: 10.1007/s00394-012-0418-1.
244. Kratz M, Marcovina S, Nelson JE, Yeh MM, Kowdley KV, Callahan HS, Song X, Di C, Utzschneider KM. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans. Am J Clin Nutr. 2014;99:1385-1396. doi: 10.3945/ajcn.113.075457.
245. Forouhi NG, Koulman A, Sharp SJ, et al. Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol. 2014;2:810-818. doi: 10.1016/S2213-8587(14)70146-9.
246. Khaw KT, Friesen MD, Riboli E, Luben R, Wareham N. Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study. PLoS Med. 2012;9:e1001255. doi: 10.1371/journal.pmed.1001255.
247. de Oliveira Otto MC, Nettleton JA, Lemaitre RN, Steffen LM, Kromhout D, Rich SS, Tsai MY, Jacobs DR, Mozaffarian D. Biomarkers of dairy fatty acids and risk of cardiovascular disease in the Multi-ethnic Study of Atherosclerosis. J Am Heart Assoc. 2013;2:e000092. doi: 10.1161/JAHA.113.000092.
248. Chowdhury R, Warnakula S, Kunutsor S, Crowe F, Ward HA, Johnson L, Franco OH, Butterworth AS, Forouhi NG, Thompson SG, Khaw KT, Mozaffarian D, Danesh J, Di Angelantonio E. Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis. Ann Intern Med. 2014;160:398-406. doi: 10.7326/M13-1788.
249. Yakoob MY, Shi P, Hu FB, Campos H, Rexrode KM, Orav EJ, Willett WC, Mozaffarian D. Circulating biomarkers of dairy fat and risk of incident stroke in U.S. men and women in 2 large prospective cohorts. Am J Clin Nutr. 2014;100:1437-1447. doi: 10.3945/ajcn.114.083097.
250. Mozaffarian D. Natural trans fat, dairy fat, partially hydrogenated oils, and cardiometabolic health - the Ludwigshafen Risk and Cardiovascular Health Study Eur Heart J. 2016;37:1079-1081. doi: 10.1093/eurheartj/ehv595.
251. Kawser Hossain M, Abdal Dayem A, Han J, Yin Y, Kim K, Kumar Saha S, Yang GM, Choi HY, Cho SG. Molecular mechanisms of the anti-obesity and anti-diabetic properties of flavonoids. Int J Mol Sci. 2016;17:569. doi: 10.3390/ijms17040569.
252. Manach C, Williamson G, Morand C, Scalbert A, Rémésy C. Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin Nutr. 2005;81:230S-242S.